Beranda › Hipertensi Arteri Pulmonal › New York
Uji klinis Hipertensi Arteri Pulmonal di New York
6 studi untuk Hipertensi Arteri Pulmonal mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- USA013, Rochester
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07481981An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- NYU Langone Health, New York
- Westchester Medical Center, Valhalla
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07365332Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- NYU Langone Health, New York
- University of Rochester Medical Center, Rochester
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT06274801Pulmonary Hypertension Association Registry
- Weill Cornell Medical Center, New York
- Columbia University Medical Center/NewYork-Presbyterian Hospital, New York
- University of Rochester Medical Center, Rochester
Menerima pesertaStudi observasional
Usia 0 ke atas · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT04071327Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Cornell University, New York
- University of Rochester, New York
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2025 · NCT04555161Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
- Columbia University Medical Center, New York
- Maria Fareri Children's Hospital at WMC Health/Westchester Medical Center, New York
Menerima pesertaStudi observasional
1 Day – 21 Years · Semua jenis kelamin · Diperbarui 13 Mar 2025 · NCT02249923Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.